101
Views
6
CrossRef citations to date
0
Altmetric
Review

Optimal delivery of follow-up care after surgery for Crohn’s disease: current perspectives

&
Pages 237-248 | Published online: 08 Aug 2016

References

  • Peyrin-BirouletLLoftusEVJrColombelJFSandbornWJThe natural history of adult Crohn’s disease in population-based cohortsAm J Gastroenterol2010105228929719861953
  • BernellOLapidusAHellersGRisk factors for surgery and postoperative recurrence in Crohn’s diseaseAnn Surg20002311384510636100
  • OlaisonGSmedhKSjodahlRNatural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptomsGut19923333313351568651
  • RutgeertsPGeboesKVantrappenGNatural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgeryGut19842566656726735250
  • RutgeertsPGeboesKVantrappenGPredictability of the postoperative course of Crohn’s diseaseGastroenterology19909949569632394349
  • RamadasAVGuneshSThomasGAWilliamsGTHawthorneABNatural history of Crohn’s disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection ratesGut20105991200120620650924
  • Peyrin-BirouletLHarmsenWSTremaineWJZinsmeisterARSandbornWJLoftusEVJrSurgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970–2004)Am J Gastroenterol2012107111693170122945286
  • PengQHWangYFHeMQZhangCTangQClinical literature review of 1858 Crohn’s disease cases requiring surgery in ChinaWorld J Gastroenterol201521154735474325914485
  • ReeseGENanidisTBorysiewiczCYamamotoTOrchardTTekkisPPThe effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studiesInt J Colorectal Dis200823121213122118762954
  • KaneSVFlickerMKatz-NelsonFTobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remissionJ Clin Gastroenterol2005391323515599207
  • McLeodRSWolffBGRossSParkesRMcKenzieMInvestigators of the CAST TrialRecurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trialDis Colon Rectum200952591992719502857
  • RissSSchusterIPapayPMittlbockMStiftARepeat intestinal resections increase the risk of recurrence of Crohn’s diseaseDis Colon Rectum201356788188723739195
  • SimillisCYamamotoTReeseGEA meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s diseaseAm J Gastroenterol2008103119620517900320
  • SacharDBLemmerEIbrahimCRecurrence patterns after first resection for stricturing or penetrating Crohn’s diseaseInflamm Bowel Dis20091571071107519229992
  • SilverbergMSSatsangiJAhmadTToward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyCan J Gastroenterol200519Suppl A5a36a
  • FerranteMde HertoghGHlavatyTThe value of myenteric plexitis to predict early postoperative Crohn’s disease recurrenceGastroenterology200613061595160616697723
  • SokolHPolinVLavergne-SloveAPlexitis as a predictive factor of early postoperative clinical recurrence in Crohn’s diseaseGut20095891218122519625280
  • BressenotAChevauxJBWillietNSubmucosal plexitis as a predictor of postoperative surgical recurrence in Crohn’s diseaseInflamm Bowel Dis20131981654166123751396
  • BernellOLapidusAHellersGRisk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn’s diseaseBr J Surg200087121697170111122187
  • WelschTHinzULofflerTEarly re-laparotomy for postoperative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn’s diseaseInt J Colorectal Dis20072291043104917390141
  • De CruzPKammMAPrideauxLAllenPBDesmondPVPostoperative recurrent luminal Crohn’s disease: a systematic reviewInflamm Bowel Dis201218475877721830279
  • MondotSLepagePSeksikPStructural robustness of the gut mucosal microbiota is associated with Crohn’s disease remission after surgeryGut201665695496226628508
  • De CruzPKangSWagnerJAssociation between specific mucosa-associated microbiota in Crohn’s disease at the time of resection and subsequent disease recurrence: a pilot studyJ Gastroenterol Hepatol201530226827825087692
  • HeXChenZHuangJStapled side-to-side anastomosis might be better than handsewn end-to-end anastomosis in ileocolic resection for Crohn’s disease: a meta-analysisDig Dis Sci20145971544155124500450
  • BressenotAPeyrin-BirouletLHistologic features predicting postoperative Crohn’s disease recurrenceInflamm Bowel Dis201521246847525437814
  • RahierJFDubuquoyLColombelJFDecreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn’s diseaseInflamm Bowel Dis201319102084209023851640
  • LiYStocchiLLiuXPresence of granulomas in mesenteric lymph nodes is associated with postoperative recurrence in Crohn’s diseaseInflamm Bowel Dis201521112613261826218143
  • BoschettiGNanceySMoussataDEnrichment of circulating and mucosal cytotoxic CD8+ T cells is associated with postoperative endoscopic recurrence in patients with Crohn’s diseaseJ Crohns Colitis201610333834526589954
  • LiYZhuWGongJVisceral fat area is associated with a high risk for early postoperative recurrence in Crohn’s diseaseColorectal Dis201517322523425307174
  • De CruzPKammMAHamiltonALCrohn’s disease management after intestinal resection: a randomised trialLancet201538599761406141725542620
  • RegueiroMManagement and prevention of postoperative Crohn’s diseaseInflamm Bowel Dis200915101583159019322907
  • BarrieARegueiroMPostoperative anti-TNF therapy in the management of Crohn’s diseaseRoglerGHerfarthHHibiTNielsenOJAnti-Tumor Necrosis Factor Therapy in Inflammatory Bowel DiseaseBael, SwitzerlandKarger2015
  • BuissonAChevauxJBBommelaerGPeyrin-BirouletLDiagnosis, prevention and treatment of postoperative Crohn’s disease recurrenceDig Liver Dis201244645346022265329
  • Van AsscheGDignassAReinischWThe second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Special situationsJ Crohns Colitis2010416310121122490
  • SinghSGargSKPardiDSWangZMuradMHLoftusEVJrComparative efficacy of pharmacologic interventions in preventing relapse of Crohn’s disease after surgery: a systematic review and network meta-analysisGastroenterology201514816476.e62 quiz e1425263803
  • DohertyGBennettGPatilSCheifetzAMossACInterventions for prevention of post-operative recurrence of Crohn’s diseaseCochrane Database Syst Rev20094Cd00687319821389
  • D’HaensGRVermeireSVan AsscheGTherapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trialGastroenterology200813541123112918727929
  • HanauerSBKorelitzBIRutgeertsPPostoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trialGastroenterology2004127372372915362027
  • ShenFCZhangHJZhaoXDCaoRSShiRHPurine analogues compared with mesalamine or 5-ASA for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysisInt J Clin Pract201266875876622805268
  • ReinischWAngelbergerSPetritschWAzathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn’s disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trialGut201059675275920551460
  • FedorakRNFeaganBGHotteNThe probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s diseaseClin Gastroenterol Hepatol2015135928935.e92225460016
  • RutgeertsPHieleMGeboesKControlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resectionGastroenterology19951086161716217768364
  • RutgeertsPVan AsscheGVermeireSOrnidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trialGastroenterology2005128485686115825069
  • ManosaMCabreEBernalIAddition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn’s disease: a randomized, double-blind, placebo-controlled trialInflamm Bowel Dis20131991889189523689809
  • AnanthakrishnanANHurCJuilleratPKorzenikJRStrategies for the prevention of postoperative recurrence in Crohn’s disease: results of a decision analysisAm J Gastroenterol2011106112009201721788991
  • ZhaoYMaTChenYFBiologics for the prevention of postoperative Crohn’s disease recurrence: a systematic review and meta-analysisClin Res Hepatol Gastroenterol201539563764925958300
  • QiuYMaoRChenBLHeYZengZRChenMHSystematic review with meta-analysis of prospective studies: anti-tumour necrosis factor for prevention of postoperative Crohn’s disease recurrenceJ Crohns Colitis201591091892726116553
  • YangZYeXWuQWuKFanDA network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn’s diseaseInt J Surg201412551652224576593
  • RegueiroMFeaganBGZouB749 infliximab for prevention of recurrence of post-surgical Crohn’s disease following ileocolonic resection: a randomized, placebo-controlled studyGastroenterology20151484S141
  • RegueiroMSchrautWBaidooLInfliximab prevents Crohn’s disease recurrence after ileal resectionGastroenterology20091362441450.e441 quiz 71619109962
  • YoshidaKFukunagaKIkeuchiHScheduled infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resection: a 3-year prospective randomized open trialInflamm Bowel Dis20121891617162322081474
  • RegueiroMKipKEBaidooLSwogerJMSchrautWPostoperative therapy with infliximab prevents long-term Crohn’s disease recurrenceClin Gastroenterol Hepatol201412914941502.e149124440221
  • ArmuzziAFeliceCPapaAPrevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot studyJ Crohns Colitis2013712e623e62923810678
  • Fernández-BlancoIMonturiolJMartinezBCaraCTaxoneraCW1291 adalimumab in the prevention of postoperative recurrence of Crohn’s diseaseGastroenterology20101385SS692
  • TursiAEliseiWPicchioMComparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot studyTech Coloproctol201418111041104624915941
  • KotzePGYamamotoTDaneseSDirect retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn’s disease: results from the MULTIPER databaseJ Crohns Colitis20159754154725820017
  • De CruzPKammMAHamiltonALEfficacy of thiopurines and adalimumab in preventing Crohn’s disease recurrence in high-risk patients – a POCER study analysisAliment Pharmacol Ther201542786787926314275
  • SavarinoEBodiniGDulbeccoPAdalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trialAm J Gastroenterol2013108111731174224019080
  • DohertyGAMiksadRACheifetzASMossACComparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn’s diseaseInflamm Bowel Dis20121891608161621905173
  • CollinsMSarterHGower-RousseauCTu1337 Anti-TNFa treatment efficacy in prevention of postoperative recurrence in Crohn’s disease depends on previous exposure to anti-TNFα agentsGastroenterology2015148(4)Suppl 1SS863
  • GagniereCBeaugerieLParienteBBenefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn’s diseaseJ Crohns Colitis20159434935525547977
  • ColombelJFSandbornWJReinischWInfliximab, azathioprine, or combination therapy for Crohn’s diseaseN Engl J Med2010362151383139520393175
  • SakurabaAOkamotoSMatsuokaKCombination therapy with infliximab and thiopurine compared to infliximab monotherapy in maintaining remission of postoperative Crohn’s diseaseDigestion201591323323825823572
  • SuzukiYKotzePGSpinelliASu1376 retrospective comparison of the efficacy of Anti-TNF agents in isolation or combined with azathioprine in prevention of early postoperative endoscopic recurrence in Crohn’s disease from the multiper databaseGastroenterology1465SS451
  • ZaghiyanKNMelmedGYDubinskyMSu1384 medical prophylaxis after ileocolic resection for Crohn’s disease – no need to rushGastroenterology1465SS454
  • BordeianouLSteinSLHoVPImmediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn’s disease?Surgery20111491727820434748
  • AngelbergerSSchaeffelerETemlAMucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn’s disease and azathioprine metabolite levelsInflamm Bowel Dis201319359059823388543
  • BodiniGSavarinoVPeyrin-BirouletLLow serum trough levels are associated with post-surgical recurrence in Crohn’s disease patients undergoing prophylaxis with adalimumabDig Liver Dis201446111043104625169962
  • Vande CasteeleNFerranteMVan AsscheGTrough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseGastroenterology2015148713201329.e132325724455
  • VaughnBPMartinez-VazquezMPatwardhanVRProactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational studyInflamm Bowel Dis201420111996200325192499
  • BrandseJFvan den BrinkGRWildenbergMELoss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitisGastroenterology20151492350355.e35225917786
  • SorrentinoDPaviottiATerrosuGLow-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s diseaseClin Gastroenterol Hepatol201087591599.e591 quiz e578–e59920139033
  • SorrentinoDMarinoMDassopoulosTZarifiDDel BiancoTLow dose infliximab for prevention of postoperative recurrence of crohn’s disease: long term follow-up and impact of infliximab trough levels and antibodies to infliximabPLoS One20151012e014490026670274
  • RegueiroMKipKESchrautWCrohn’s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resectionInflamm Bowel Dis201117111812620848538
  • YamamotoTBambaTUmegaeSMatsumotoKThe impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn’s disease: a 5-year prospective cohort studyUnited European Gastroenterol J201314294298
  • MitselosIVChristodoulouDKKatsanosKHTsianosEVRole of wireless capsule endoscopy in the follow-up of inflammatory bowel diseaseWorld J Gastrointest Endosc20157664365126078832
  • MaoRGaoXZhuZHCT enterography in evaluating postoperative recurrence of Crohn’s disease after ileocolic resection: complementary role to endoscopyInflamm Bowel Dis201319597798223511036
  • MinordiLMVecchioliAPoloniGGuidiLDe VitisIBonomoLEnteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn’s disease: CT findings and correlation with endoscopyEur Radiol200919102432244019415289
  • Gallego OjeaJCEcharri PiudoAIPorta VilaACrohn’s disease: the usefulness of MR enterography in the detection of recurrence after surgeryRadiologia201153655255921450324
  • SoyerPBoudiafMSirolMSuspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysisRadiology2010254375576420177090
  • SailerJPeloschekPReinischWVogelsangHTuretschekKSchimaWAnastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopyEur Radiol200818112512252118504592
  • KoilakouSSailerJPeloschekPEndoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn’s disease after ileocolic resectionInflamm Bowel Dis201016219820319504611
  • ErcoleERigazioCRole of bowel ultrasound in the management of postoperative Crohn’s diseaseWorld J Gastrointest Pathophysiol20145445746125400989
  • LassonAStridHOhmanLFecal calprotectin one year after ileocaecal resection for Crohn’s disease – a comparison with findings at ileocolonoscopyJ Crohns Colitis20148878979524418661
  • YamamotoTShirakiMBambaTUmegaeSMatsumotoKFaecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: a prospective pilot studyUnited European Gastroenterol J201315368374
  • LobatonTLopez-GarciaARodriguez-MorantaFRuizARodríguezLGuardiolaJA new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn’s diseaseJ Crohns Colitis2013712e641e65123810085
  • QiuYMaoRChenBLFecal calprotectin for evaluating postoperative recurrence of Crohn’s disease: a meta-analysis of prospective studiesInflamm Bowel Dis201521231532225569739
  • BoschettiGLaidetMMoussataDLevels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn’s diseaseAm J Gastroenterol2015110686587225781366
  • WrightEKKammMADe CruzPMeasurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn’s disease after surgeryGastroenterology20151485938947.e93125620670
  • SchoepferAMLewisJDSerial fecal calprotectin measurements to detect endoscopic recurrence in postoperative Crohn’s disease: is colonoscopic surveillance no longer needed?Gastroenterology2015148588989225805423
  • SorrentinoDTerrosuGPaviottiAEarly diagnosis and treatment of postoperative endoscopic recurrence of Crohn’s disease: partial benefit by infliximab – a pilot studyDig Dis Sci20125751341134822252267
  • YamamotoTUmegaeSMatsumotoKImpact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn’s disease: a prospective pilot studyInflamm Bowel Dis200915101460146619266566
  • BouguenGLevesqueBGFeaganBGTreat to target: a proposed new paradigm for the management of Crohn’s diseaseClin Gastroenterol Hepatol201513610421050.e104224036054
  • Peyrin-BirouletLSandbornWSandsBESelecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-targetAm J Gastroenterol201511091324133826303131
  • BaudryCParienteBLourencoNTailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn’s disease: a retrospective studyDig Liver Dis2014461088789225081846
  • Gonzalez-LamaYBlazquezISuarezCJImpact of endoscopic monitoring in postoperative Crohn’s disease patients already receiving pharmacological prevention of recurrenceRev Esp Enferm Dig20151071058659026437976
  • FerranteMPapamichaelKDuricovaDSystematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn’s disease recurrenceJ Crohns Colitis20159861762425926532
  • BryantRVSandbornWJTravisSPIntroducing vedolizumab to clinical practice: who, when, and how?J Crohns Colitis20159435636625687206
  • PoulakosMMachinJDPaulyJGraceYVedolizumab: a new opponent in the battle against Crohn’s disease and ulcerative colitisJ Pharm Pract Epub 562015
  • TargownikLEConeysJGDhillonASEmerging issues in the medical management of Crohn’s diseaseCurr Opin Gastroenterol201632210310926839964
  • RutgeertsPGoboesKPeetersMEffect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileumLancet199133887707717741681159
  • VaughnBPMossACPrevention of post-operative recurrence of Crohn’s diseaseWorld J Gastroenterol20142051147115424574791
  • O’connorATaylorJRobertsLPTU-067 How are postoperative crohn’s patients followed up? a retrospective analysis from a tertiary referral centreGut201564Suppl 1A89